Witnessing the stock’s movement on the chart, on Thursday, Genelux Corp (NASDAQ: GNLX) set off with pace as it heaved 19.41% to $2.83, before settling in for the price of $2.37 at the close. Taking a more long-term approach, GNLX posted a 52-week range of $1.60-$30.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -24.62% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -23.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 23.10%. This publicly-traded company’s shares outstanding now amounts to $34.54 million, simultaneously with a float of $27.55 million. The organization now has a market capitalization sitting at $97.75 million. At the time of writing, stock’s 50-day Moving Average stood at $2.13, while the 200-day Moving Average is $6.19.
Genelux Corp (GNLX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Genelux Corp’s current insider ownership accounts for 20.24%, in contrast to 20.50% institutional ownership. According to the most recent insider trade that took place on Aug 30 ’24, this organization’s 10% Owner sold 142,589 shares at the rate of 2.17, making the entire transaction reach 309,846 in total value, affecting insider ownership by 782,639. Preceding that transaction, on Aug 29 ’24, Company’s 10% Owner sold 107,045 for 1.98, making the whole transaction’s value amount to 211,960. This particular insider is now the holder of 925,228 in total.
Genelux Corp (GNLX) Earnings and Revenue Records
Genelux Corp’s EPS increase for this current 12-month fiscal period is 23.10% and is forecasted to reach -0.97 in the upcoming year.
Genelux Corp (NASDAQ: GNLX) Trading Performance Indicators
Let’s observe the current performance indicators for Genelux Corp (GNLX). It’s Quick Ratio in the last reported quarter now stands at 6.01. The Stock has managed to achieve an average true range (ATR) of 0.25. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9774.82.
In the same vein, GNLX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.97, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.97 at the market close of one year from today.
Technical Analysis of Genelux Corp (GNLX)
Going through the that latest performance of [Genelux Corp, GNLX]. Its last 5-days volume of 0.27 million indicated improvement to the volume of 0.19 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 64.98% While, its Average True Range was 0.27.
Raw Stochastic average of Genelux Corp (GNLX) in the period of the previous 100 days is set at 29.64%, which indicates a major fall in contrast to 86.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 110.86% that was lower than 140.89% volatility it exhibited in the past 100-days period.
